Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
The cannabis industry is continuing to explode around the world and, at its current pace, is projected to balloon to a market value of nearly $60 billion by 2027, according to cannabis data company BDSA.
U.S. markets ended mostly lower on the first day of March, on data indicating inflation is likely to stay high and Federal Reserve policymakers hinted support for more aggressive rate hikes. Cheddar News speaks with Sam Stovall, Chief Investment Strategist at CFRA who breaks down the market's action.
A report shows that a majority of young adults get their money advice on social media. Kendall Meade, financial planner at SoFi, joined Cheddar News to explain how to vet economic tips on social media.